Mediplantex National Pharmaceutical JSC (HNX:MED)

Market Cap	301.56B
Revenue (ttm)	360.49B
Net Income (ttm)	11.61B
Shares Out	12.41M
EPS (ttm)	935.19
PE Ratio	25.98
Forward PE	n/a
Dividend	900.00 (3.70%)
Ex-Dividend Date	Jul 16, 2025

Volume	175
Average Volume	896
Open	24,300
Previous Close	23,300
Day's Range	24,300 - 24,300
52-Week Range	22,200 - 28,600
Beta	0.10
RSI	46.67
Earnings Date	Jul 29, 2025

About Regulus Therapeutics

Mediplantex National Pharmaceutical Joint Stock Company produces and trades in pharmaceutical products in Vietnam and internationally. The company offers pharmaceutical products in various categories, including drugs from herbals; analgesics, corticosteroid, and anti-inflammatory drugs; antibiotics; cerebral circulation, heart, and lung drugs; anti-malarial, demostasis, gout, diabetes, allergies, and osteoarthritis drugs; acid amin, vitamins, and minerals; and other products. It also provides pharmaceutical chemicals and medicinal herbs; and ex...

• Industry: Pharmaceutical Preparations
• Founded: 1958
• Employees: 450
• Stock Exchange: Hanoi Stock Exchange
• Ticker Symbol: MED

Financial Performance

In 2024, HNX:MED's revenue was 443.14 billion, an increase of 10.79% compared to the previous year's 399.96 billion. Earnings were 15.18 billion, an increase of 28.26%.